(Q46456059)

22 December 2017

title

Women age < or = 35 years with primary breast carcinoma: disease features at presentation (English)

1 reference

22 December 2017

Ana Maria Gonzalez-Angulo

1 reference

1

object named as

Ana M Gonzalez-Angulo

1 reference

22 December 2017

Gabriel N Hortobagyi

10

object named as

Gabriel N Hortobagyi

1 reference

22 December 2017

Aman U Buzdar

9

object named as

Aman U Buzdar

1 reference

22 December 2017

author name string

Kristine Broglio

2

1 reference

22 December 2017

Shu-Wan Kau

3

1 reference

22 December 2017

Yesmin Eralp

4

1 reference

22 December 2017

Julie Erlichman

5

1 reference

22 December 2017

Vicente Valero

6

1 reference

22 December 2017

Richard Theriault

7

1 reference

22 December 2017

Daniel Booser

8

1 reference

22 December 2017

Banu Arun

11

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

22 December 2017

published in

Cancer

1 reference

22 December 2017

volume

103

1 reference

22 December 2017

issue

12

1 reference

22 December 2017

page(s)

2466-2472

1 reference

22 December 2017

Breast carcinomas occurring in young women (< 35 years) are different

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

The relation between survival and age at diagnosis in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Younger women with breast carcinoma have a poorer prognosis than older women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

The world Health Organization Histological Typing of Breast Tumors--Second Edition. The World Organization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Menstrual factors and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Review of anthropometric factors and breast cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Breast cancer prognosis in relation to family history of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Is survival among women diagnosed with breast cancer influenced by family history of breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

BRCA-associated breast cancer in young women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21070

7 January 2021

Identifiers

DOI

10.1002/CNCR.21070

1 reference

22 December 2017

release_5tszf2acxvbrzc5xvg534clgya

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5tszf2acxvbrzc5xvg534clgya

24 November 2022

mapped directly with Wikidata item

1 reference

22 December 2017